🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/11/2009 | 7,22 | 7,52 | 6,77 | 7,41 | +2,06% | 10,36% | 462.946 |
| 27/11/2009 | 7,41 | 7,64 | 7,26 | 7,26 | -3,96% | 5,05% | 85.493 |
| 25/11/2009 | 7,97 | 7,97 | 7,52 | 7,56 | -5,17% | 5,63% | 77.906 |
| 24/11/2009 | 8,23 | 8,35 | 7,90 | 7,97 | -3,18% | 5,46% | 48.411 |
| 23/11/2009 | 8,23 | 8,95 | 8,08 | 8,23 | +4,27% | 10,45% | 107.802 |
| 20/11/2009 | 8,16 | 8,35 | 7,64 | 7,90 | +0,48% | 8,72% | 94.951 |
| 19/11/2009 | 9,06 | 9,10 | 7,86 | 7,86 | -11,02% | 13,64% | 209.753 |
| 18/11/2009 | 8,23 | 8,91 | 8,20 | 8,83 | +7,76% | 8,64% | 176.277 |
| 17/11/2009 | 7,94 | 8,20 | 7,71 | 8,20 | +3,30% | 6,13% | 90.249 |
| 16/11/2009 | 7,56 | 8,01 | 7,56 | 7,94 | +6,00% | 5,94% | 118.328 |
| 13/11/2009 | 7,64 | 7,75 | 7,45 | 7,49 | -1,48% | 3,92% | 200.081 |
| 12/11/2009 | 7,49 | 7,79 | 7,41 | 7,60 | +1,00% | 5,00% | 82.501 |
| 11/11/2009 | 7,56 | 7,64 | 7,41 | 7,52 | +2,03% | 2,97% | 72.963 |
| 10/11/2009 | 7,45 | 7,64 | 7,19 | 7,37 | -1,50% | 6,03% | 60.967 |
| 09/11/2009 | 7,52 | 7,67 | 7,34 | 7,49 | +0,00% | 4,48% | 80.444 |
| 06/11/2009 | 7,45 | 7,94 | 7,11 | 7,49 | +4,71% | 11,05% | 145.873 |
| 05/11/2009 | 6,29 | 7,22 | 6,25 | 7,15 | +15,06% | 15,48% | 129.977 |
| 04/11/2009 | 6,59 | 6,70 | 6,18 | 6,21 | -5,14% | 7,95% | 81.299 |
| 03/11/2009 | 6,36 | 6,55 | 6,18 | 6,55 | +1,74% | 5,88% | 113.546 |
| 02/11/2009 | 6,40 | 6,63 | 6,10 | 6,44 | +1,18% | 8,19% | 123.912 |
| 30/10/2009 | 6,59 | 6,70 | 6,29 | 6,36 | -4,49% | 6,25% | 168.048 |
| 29/10/2009 | 7,11 | 7,22 | 6,63 | 6,66 | -4,81% | 8,42% | 181.860 |
| 28/10/2009 | 7,04 | 7,11 | 6,92 | 7,00 | -0,53% | 2,66% | 105.157 |
| 27/10/2009 | 7,15 | 7,37 | 7,04 | 7,04 | -1,57% | 4,71% | 106.867 |
| 26/10/2009 | 7,56 | 7,82 | 7,11 | 7,15 | -5,45% | 9,41% | 73.978 |
| 23/10/2009 | 8,08 | 8,08 | 7,49 | 7,56 | -6,48% | 7,41% | 105.584 |
| 22/10/2009 | 7,56 | 8,08 | 7,45 | 8,08 | +6,93% | 8,42% | 124.633 |
| 21/10/2009 | 7,86 | 8,08 | 7,49 | 7,56 | -4,27% | 7,62% | 110.901 |
| 20/10/2009 | 8,20 | 8,20 | 7,86 | 7,90 | -4,09% | 4,11% | 158.563 |
| 19/10/2009 | 8,42 | 8,42 | 8,05 | 8,23 | +2,33% | 4,44% | 114.935 |